Insider selling at Northern Oil and Gas, without insider buying, raises concerns about the company's prospects. Low level of insider ownership suggests a lack of alignment with shareholders, making us cautious about the company.
Despite impressive ROE from Northern Oil and Gas, their high debt levels pose concerns. Investors should think about performance amidst unfavorable credit markets. Optimal companies should show high ROE and low debt. Future profit growth and necessary investment are also key in determining buy-in price.
Northern Oil and Gas' impressive performance in the long term, along with the company becoming profitable, validates its robust share price. The market will likely keep a close watch, considering possible risks.
Gapping up •$ノーザン オイル アンド ガス(NOG.US)$+6.1% (to join S&P SmallCap 600) •$アメリカン エキスプレス(AXP.US)$+ 5.3% (Fourth-quarter results at American Express fell short of expectations but Wall Street was more interested in the company’s plans to return capital to shareholders) •$ロッキード マーチン(LMT.US)$+0.6% (awarded $657 mln U.S. Army contract modification) Gapping down •$インテル(INTC.US)$-10.5% (Intel reported its Q4 2022...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Energy Transfer LP$Evertz Technologies Ltd(ET.CA)$has "got a nice yield. I do like the pipeline companies very much. ET’s a win." When asked about Northern Oil and Gas, Inc. NOG$ノーザン オイル アンド ガス(NOG.US)$, he said, "I’d rather see you in something that right now, works." "I believe that it is a call option on natural gas," Cramer said, when asked about ...
Gainers -$ルナイノベーション(LUNA.US)$+8.55% (acquires LIOS Sensing from NKT A/S' NKT Photonics for 20 million in cash; divested Luna Labs for $21 mln) -$クレネ(CLNN.US)$+3.5% (Presents Updated Clinical Data from Phase 2 RESCUE-ALS and REPAIR trials and Preclinical ALS data at 2022 MDA Clinical & Scientific Conference) -$アストラゼネカ(AZN.US)$+2.3% ( AstraZeneca and$メルク(MRK.US)$'s Lynparza (olaparib) has been approved in the ...
ノーザン オイル アンド ガスに関するコメント
• $ノーザン オイル アンド ガス(NOG.US)$ +6.1% (to join S&P SmallCap 600)
• $アメリカン エキスプレス(AXP.US)$ + 5.3% (Fourth-quarter results at American Express fell short of expectations but Wall Street was more interested in the company’s plans to return capital to shareholders)
• $ロッキード マーチン(LMT.US)$ +0.6% (awarded $657 mln U.S. Army contract modification)
Gapping down
• $インテル(INTC.US)$ -10.5% (Intel reported its Q4 2022...
When asked about Northern Oil and Gas, Inc.
NOG $ノーザン オイル アンド ガス(NOG.US)$ , he said, "I’d rather see you in something that right now, works."
"I believe that it is a call option on natural gas," Cramer said, when asked about ...
• $Livent(LTHM.US)$ +22.58% (it posted better-than-expected quarterly earnings and raised its 2022 revenue forecast)
• $スーパー マイクロ コンピューター(SMCI.US)$ +11.01% (earnings reports)
• $オートリー・グループAB(OTLY.US)$ +8.31% (earnings reports)
• $ブルーリンクス ホールディングス(BXC.US)$ +9.7% (increases share repurchase authorization to $100 mln; enters into $60 mln accelerated repurchase agreement)
• $スターバックス(SBUX.US)$ +7.18% (matched estimates wi...
• $アセンディス・ファーマ(ASND.US)$: BofA Securities Upgrades to Buy from Neutral - PT $161 (from $148)
• $GOODRXホールディングス(GDRX.US)$: Baird Upgrades to Outperform from Neutral - PT $17
• $WW グレインジャー(GWW.US)$: Atlantic Equities Upgrades to Overweight from Neutral - PT $580 (from $520)
• $ハートランド エクスプレス(HTLD.US)$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $16
• $モザイク(MOS.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $83
• $ノーザン オイル アンド ガス(NOG.US)$: Johnson ...
- $ルナイノベーション(LUNA.US)$ +8.55% (acquires LIOS Sensing from NKT A/S' NKT Photonics for 20 million in cash; divested Luna Labs for $21 mln)
- $クレネ(CLNN.US)$ +3.5% (Presents Updated Clinical Data from Phase 2 RESCUE-ALS and REPAIR trials and Preclinical ALS data at 2022 MDA Clinical & Scientific Conference)
- $アストラゼネカ(AZN.US)$ +2.3% ( AstraZeneca and $メルク(MRK.US)$ 's Lynparza (olaparib) has been approved in the ...
• $BRPグループ A(BRP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $31
• $Centennial Resource Development(CDEV.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $12 (from $8)
• $エノバ インターナショナル(ENVA.US)$ : Janney Upgrades to Buy from Neutral - PT $49
• $フォーティブ(FTV.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $75
• $ヘリオス テクノロジーズ(HLIO.US)$ : KeyBanc Upgrades to Overweight from Sector Weight - PT $90
• $ヘルマリック アンド ペイン(HP.US)$ : Seaport...
まだコメントはありません